Skip to main content
. Author manuscript; available in PMC: 2021 Jan 13.
Published in final edited form as: J Clin Lipidol. 2020 Jan 13;14(1):143–153. doi: 10.1016/j.jacl.2020.01.002

Table 1.

Characteristics of the participants (n=1868)

Characteristic Mean (SD)/Percent (n)
Age (years, M [SD]) 64.7 (9.8)
Female (% [n]) 50.3 (940)
Ethnicity (% [n])
  White 40.0 (747)
  Chinese American 13.2 (247)
  African American 21.1 (394)
  Hispanic 25.7 (480)
Ever Smoker (% [n]) 54.0 (1008)
Dyslipidemia (% [n]) 37.6 (702)
Diabetes (% [n]) 13.7 (256)
Hypertension (% [n]) 46.7 (872)
Taking lipid lowering medications (% [n]) 24.1 (451)
Body Composition
 BMI (M [SD]) 28.0 (5.1)
 Subcutaneous fat area (cm2, M [SD]) 253.7 (117.4)
 Visceral fat area (cm2, M [SD]) 145.7 (67.9)
 Abdominal muscle area (cm2, M [SD]) 98.3 (27.6)
 Stability muscle area (cm2, M [SD]) 74.6 (21.8)
 Locomotor muscle area (cm2, M [SD]) 23.7 (7.4)
 Abdominal muscle density (HU, M [SD]) 42.2 (5.5)
 Stability muscle density (HU, M [SD]) 39.6 (6.1)
 Locomotor muscle density (HU, M [SD]) 50.3 (5.2)
Activity Levels
 Sedentary Behavior (min·wk−1, Mdn [IQR]) 1470 (1455)
 MVPA (MET-min·wk−1, Mdn [IQR]) 3600 (4549)
Cardiovascular Disease Risk Factors
 Systolic blood pressure (mmHg, M [SD]) 124 (21)
 Diastolic blood pressure (mmHg, M [SD]) 70 (10)
 Triglycerides (mg·dL−1, M [SD]) 126.8 (66.2)
 Total cholesterol (mg·dL−1, M [SD]) 189.3 (35.2)
 High-density lipoprotein (mg·dL−1, M [SD]) 51.8 (15.1)
 Low-density lipoprotein (mg·dL−1, M [SD]) 112.0 (31.3)
 Very low-density lipoprotein (mg·dL−1, M [SD]) 26.4 (16.4)
 Non-high-density lipoprotein (mg·dL−1, M [SD]) 138.0 (35.5)
 Total to HDL cholesterol ratio 3.9 (1.2)
Inflammatory Markers
 C-reactive protein (mg·L−1, Mdn [IQR] 1.5 (2.6)
 Adiponectin (μg·mL−1, Mdn [IQR]) 17.5 (14.6)
 Leptin (ng·mL−1, Mdn [IQR]) 13.2 (22.5)
 Resistin (ng·mL−1, Mdn [IQR]) 15.0 (7.2)
 Interleukin-6 (pg·mL−1, Mdn [IQR]) 1.8 (1.7)
 TNF-α (pg·mL−1, Mdn [IQR]) 4.6 (2.9)

M, mean; SD, standard deviation; %, percent; n, sample size; Mdn, median; IQR, interquartile range; BMI, body mass index; HU, Hounsfield units; MVPA, moderate-to-vigorous physical activity; MET, metabolic equivalents; TNF-α, tumor necrosis factor alpha. Note: SI conversion factors: To convert glucose, cholesterol, and triglycerides to mmol·L−1, multiply values by 0.0555, 0.0259, and 0.0113, respectively. To convert C-reactive protein to nmol·L−1, multiply values by 9.524.